Updated recommendations to managing type 2 diabetes with SGLT2 inhibitors and GLP-1 receptor agonists and preventing cardiovascular events.
EP. 1: Geographic Disparities in T2DM and CVD Prevention
A call to action for more focus on the management of the type 2 diabetes epidemic around the globe.
EP. 2: Blood Pressure Management and CVD Prevention in T2DM
Updated guideline recommendations regarding the monitoring and management of patients’ blood pressure levels to reduce the risk of cardiovascular events.
EP. 3: Cholesterol-Lowering Therapies for CVD Prevention in T2DM
Considerations that factor into decisions for reducing LDL levels in patients with diabetes with statin therapy or options, such as PCSK9 inhibitors and ezetimibe.
EP. 4: Statin Therapies and Treatment-Related Myalgias
How to best prevent and manage statin-associated myalgias when managing cholesterol levels in patients with type 2 diabetes at risk for cardiovascular events.
EP. 5: Updated Guidance Regarding Aspirin Use and CVD Prevention
Guidance on the use of aspirin therapy in patients at risk of cardiovascular events, based on recently updated guideline recommendations.
EP. 6: Revised ADA Guideline Recommendations for the Treatment of T2DM
Takeaways of the most recent ADA guidelines in terms of treating patients with diabetes with metformin, SGLT2 inhibitors, and GLP-1 receptor agonists.
EP. 7: Benefits of New Therapies Used to Treat T2DM
The benefits of using new therapies, such as SGLT2 inhibitors and GLP-1 receptor agonists, to treat type 2 diabetes.
EP. 8: Continuous Glucose Monitoring Systems for T2DM
A discussion on using continuous glucose monitoring systems to improve the management of type 2 diabetes.
EP. 9: Integrating Continuous Glucose Monitoring Systems into Clinical Practice
Recommendations to address accessibility and coverage issues that affect the use of continuous glucose monitoring into widespread clinical practice.
EP. 10: Hybrid Artificial Insulin Pump Systems for T2DM
A description of hybrid artificial insulin pump systems for type 2 diabetes and a discussion highlighting potential integration with continuous glucose monitoring systems.
EP. 11: Gestational Diabetes and Cardiovascular Disease Risk
Guidance in terms of counseling women on pregnancy, gestational diabetes, and the risk for cardiovascular events.
EP. 12: New Technologies, Type 2 Diabetes, and Cardiovascular Prevention
Limitations managing type 2 diabetes with new technologies used as monitoring tools that need to be addressed moving forward.
2 Clarke Drive Cranbury, NJ 08512